<--- Back to Details
First PageDocument Content
Proteobacteria / Meningococcal disease / Vaccines / Novartis / Meningitis / Neisseria meningitidis / Neisseria / Meningococcal vaccine / Bacteria / Microbiology / Medicine
Date: 2014-04-23 10:51:27
Proteobacteria
Meningococcal disease
Vaccines
Novartis
Meningitis
Neisseria meningitidis
Neisseria
Meningococcal vaccine
Bacteria
Microbiology
Medicine

Novartis International AG Novartis Global Communications CH-4002 Basel Switzerland http://www.novartis.com

Add to Reading List

Source URL: www.novartisvaccines.com

Download Document from Source Website

File Size: 182,09 KB

Share Document on Facebook

Similar Documents

Meningococcal Vaccine Q & A for Healthcare Providers

Meningococcal Vaccine Q & A for Healthcare Providers

DocID: 1uSKv - View Document

Vaccine Information Statement: Serogroup A, C, W, Y Meningococcal Vaccines (MenACWY and MPSV4): What you need to know

Vaccine Information Statement: Serogroup A, C, W, Y Meningococcal Vaccines (MenACWY and MPSV4): What you need to know

DocID: 1uqvE - View Document

Meningitis Statement Georgia state law requires all students residing in University housing to receive information about meningococcal disease. Evidence suggests that college students are at an increased risk of contract

Meningitis Statement Georgia state law requires all students residing in University housing to receive information about meningococcal disease. Evidence suggests that college students are at an increased risk of contract

DocID: 1rsYu - View Document

New York State Department of Health

New York State Department of Health

DocID: 1rfHH - View Document

University of California Immunization Requirements & Recommendations

University of California Immunization Requirements & Recommendations

DocID: 1rc3a - View Document